Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

640 ARTÍCULOS , VIENDO DEL 76 AL 90

Auditory Brainstem Dysfunction, Non-Invasive Biomarkers for Early Diagnosis and Monitoring of Alzheimer's Disease in Young Urban Residents Exposed to Air Pollution

Mansour Y, Blackburn K, González-González LO, Calderón-Garcidueñas L, Kulesza RJ.

J Alzheimers Dis. 2019;67(4):1147-1155. doi: 10.3233/JAD-181186.

The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans

Stepler KE, Robinson RAS.

Adv Exp Med Biol. 2019;1118:1-28. doi: 10.1007/978-3-030-05542-4_1.

Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms

Takatori S, Wang W, Iguchi A, Tomita T.

Adv Exp Med Biol. 2019;1118:83-116. doi: 10.1007/978-3-030-05542-4_5.

Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis

Ruthirakuhan M, Lanctôt KL, Vieira D, Herrmann N.

J Clin Psychiatry. 2019 Jan 29;80(2):18r12617. doi: 10.4088/JCP.18r12617.

Young adult-onset, very slowly progressive cognitive decline with spastic paraparesis in Alzheimer's disease with cotton wool plaques due to a novel presenilin1 G417S mutation

Miki T, Yokota O, Haraguchi T, Ikeuchi T, Zhu B, Takenoshita S, Terada S, Yamada N.

Acta Neuropathol Commun. 2019 Feb 12;7(1):19. doi: 10.1186/s40478-019-0672-z.

WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis

Georgakis MK, Duering M, Wardlaw JM, Dichgans M.

Neurology. 2019 Mar 19;92(12):e1298-e1308. doi: 10.1212/WNL.0000000000007142. Epub 2019 Feb 15.

Air Pollution and Dementia: A Systematic Review

Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ.

J Alzheimers Dis. 2019;70(s1):S145-S163. doi: 10.3233/JAD-180631.

Cognitive Improvement with Glutathione Supplement in Alzheimer's Disease: A Way Forward

Mandal PK, Shukla D, Tripathi M, Ersland L.

J Alzheimers Dis. 2019;68(2):531-535. doi: 10.3233/JAD-181054.

Is Alzheimer's Disease Risk Modifiable?

Serrano-Pozo A, Growdon JH.

J Alzheimers Dis. 2019;67(3):795-819. doi: 10.3233/JAD181028.

Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND)

Sinharay S, Hammoud DA.

Curr HIV/AIDS Rep. 2019 Feb;16(1):66-75. doi: 10.1007/s11904-019-00419-8.

The impact of dementia on hospital outcomes for elderly patients with sepsis: A population-based study

Bouza C, Martínez-Alés G, López-Cuadrado T.

PLoS One. 2019 Feb 19;14(2):e0212196. doi: 10.1371/journal.pone.0212196. eCollection 2019.

Emergence of artistic talent in progressive nonfluent aphasia: a case report

Hamauchi A, Hidaka Y, Kitamura I, Yatabe Y, Hashimoto M, Yonehara T, Fukuhara R, Ikeda M.

Psychogeriatrics. 2019 Nov;19(6):601-604. doi: 10.1111/psyg.12437. Epub 2019 Feb 19.

Sleep Disturbance as a Potential Modifiable Risk Factor for Alzheimer's Disease

Minakawa EN, Wada K, Nagai Y.

Int J Mol Sci. 2019 Feb 13;20(4):803. doi: 10.3390/ijms20040803.

Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis

Peters R, Booth A, Rockwood K, Peters J, D'Este C, Anstey KJ.

BMJ Open. 2019 Jan 25;9(1):e022846. doi: 10.1136/bmjopen-2018-022846.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Varatharajah Y, Ramanan VK, Iyer R, Vemuri P; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 19;9(1):2235. doi: 10.1038/s41598-019-38793-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias